Navigation Links
Unique Pharmaceuticals Applauds Passage of Drug Quality and Security Act
Date:11/26/2013

TEMPLE, Texas, Nov. 26, 2013 /PRNewswire/ -- Unique Pharmaceuticals, Ltd., (UPI), a leading specialty compounding pharmacy, fully supports the recently passed Drug Quality and Security Act and applauds members of both chambers of congress for creating much-needed industry oversight and establishing more rigorous standards.

"Everyone at Unique Pharmaceuticals is committed to maintaining and exceeding the highest level of quality and safety for our customers," said Unique Pharmaceuticals President Travis A. Leeah, RPh, MBA, who has championed UPI's involvement with regulators on both the state and federal levels. "The legislation reflects a significant step forward and helps ensure the integrity of the customized, compounded sterile medications that are administered to patients in virtually all U.S. hospitals."

The full passage of the Drug Quality and Security Act brings definition to the regulation of the compounding industry by establishing a new oversight section of the U.S. Food and Drug Administration (FDA) for "outsourcing facilities" like Unique. This new category of large sterile compounders will be held to rigorous requirements and subject to routine FDA inspections.

Unique Pharmaceuticals is already registered with the FDA and makes significant investments of both capital and human resources to maintain the agency's standards. Unique's "Quality by Design" program additionally meets applicable Good Manufacturing Practices and as well as USP 797 standards. 

In May, the company adopted Chemunex ScanRDI technology across their operations to confirm sterility of all preparations developed in their laboratory. UPI is one of the very few compounding pharmacies in the U.S. with the capability to detect and identify any microorganism in a raw ingredient or preparation – down to one microbial cell – within 48 hours. Compounders typically ship preparations to a third-party laboratory to confirm sterility requiring a 14-day incubation period before they are confirmed sterile and ready to be administered.

About Unique Pharmaceuticals, Ltd.
Unique Pharmaceuticals, Ltd., (UPI) is a PCAB Accredited™ specialty compounding pharmacy dedicated to improving quality of life and providing trusted preparations for clinics, hospitals and surgery centers throughout the United States. UPI has more than 15 years of industry experience and is ISO 9001:2008 certified, VAWD (Verified-Accredited Wholesale Distributors) accredited and USP Chapter 797 compliant. The company is headquartered in Temple, Texas, and is committed to delivering quality, assurance and peace of mind with every solution. For more information, please visit www.upisolutions.com or call 888-339-0874. 

Contact:
Amanda Anderson
amanda@lovell.com
615-297-7766 


'/>"/>
SOURCE Unique Pharmaceuticals, Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate
2. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
3. Cardinal Health, Detroit Medical Center, Henry Ford Health System Announce Unique Collaboration To Promote Urban Renewal
4. Unique Conference Tackles Opioid Abuse Epidemic
5. Fidelitas Launches Unique Methadone Documentation and Dispensing System in Canada
6. FDA Proposes Unique Device Identification Regulations for Medical Devices
7. Novation Applauds FDAs Unique Device Identification Rule
8. Verify Brand Supports the Proposed FDA Unique Device Identification (UDI) System for Medical Devices
9. Results For Phase 2b Trial Of Unique Investigational Cell-Based Therapy In Venous Leg Ulcers Published In The Lancet
10. Sentara Healthcare, MDLIVE Forge Unique Equity Partnership in Virtual Medicine
11. MedQIA unique CAD algorithm for Quantitation of lung involvement in diffuse lung disease used as treatment efficacy end point in study to be reported at the ERS Annual Conference in Vienna, Austria: September 1-5, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Dec. 8, 2016 Dignitana, a world leader ... with Boa® Technology, creator of the award-winning, patented Boa® ... use with the DigniCap® scalp cooling system. DigniCap® was ... December 2015, and is the first medical scalp cooling ... scalp cooling system features a patented tight-fitting silicone cooling ...
(Date:12/8/2016)... in the United States will continue in 2017, say ... December 2016 Semiannual Economic Forecast. Expectations are for a ... as indicated in the monthly ISM ® ... is optimistic about growth in 2017, with revenues expected ... sector indicates that 14 of its industries will see ...
(Date:12/8/2016)... 8, 2016 According to a new market research ... Fetal), Therapeutic (Pain, Insulin)), End Use (Sports, Fitness, RPM), Type (Smart watch, ... the global market, in terms of value, is projected to reach 12.14 ... of 18.0% during the forecast period. Continue ... ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... 08, 2016 , ... ZyDoc , a New York-based ... Data Capture Methods for Input to Electronic Health Records: A Comparative Usability Study” ... comparative usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s MediSapien™ ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s leading digital and ... with Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media Group ... said, “CURE Media Group is honored to team up with Upstage Lung Cancer in ...
(Date:12/8/2016)... ... 2016 , ... Premier Fitness Camp (PFC) and The Chopra Center for Wellbeing ... wellness program, at their world headquarters of Omni La Costa Resort & Spa in ... anyone seeking weight loss, personal development, a healthy lifestyle, or mental and physical healing. ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... up in 2006 as a non-profit organization to unite pharmaceutical and healthcare companies ...
(Date:12/8/2016)... ... ... California Senate Bill (SB) 863, signed into law in 2012, may have ... according to CompScope™ Medical Benchmarks for California, 17th Edition , a study by ... payments per claim in California decreased 4 percent in 2013 and then 3 percent ...
Breaking Medicine News(10 mins):